PMID- 34592827
OWN - NLM
STAT- MEDLINE
DCOM- 20211018
LR  - 20211018
IS  - 1938-1344 (Electronic)
IS  - 0190-6011 (Linking)
VI  - 51
IP  - 10
DP  - 2021 Oct
TI  - Victorian Institute of Sport Assessment-Achilles (VISA-A) Questionnaire-Minimal 
      Clinically Important Difference for Active People With Midportion Achilles 
      Tendinopathy: A Prospective Cohort Study.
PG  - 510-516
LID - 10.2519/jospt.2021.10040 [doi]
AB  - OBJECTIVE: To determine the minimal clinically important difference (MCID) for 
      the Victorian Institute of Sport Assessment-Achilles (VISA-A) score in patients 
      with midportion Achilles tendinopathy (AT). DESIGN: Prospective cohort study. 
      METHODS: We included physically active patients with midportion AT who received 
      exercises and an injection. We measured the VISA-A score (ranging from 0 to 100 
      points, where 100 points represents a healthy tendon) at baseline and at 12 weeks 
      and 24 weeks after treatment, and the 7-point Global Assessment Scale (ranging 
      from "worse than ever" to "completely recovered") at 12 weeks and 24 weeks after 
      treatment. We dichotomized the Global Assessment Scale to not improved ("worse 
      than ever" to "unchanged") or improved ("moderately improved" to "completely 
      recovered"). The area under the curve and the Youden's index value closest to 1 
      were determined for both MCIDs (12 and 24 weeks), with corresponding sensitivity 
      and specificity. RESULTS: Sixty-four patients were included, and 61 patients 
      (95%) completed the 24-week follow-up. The MCID was 14 points (95% confidence 
      interval [CI]: 3, 19) over a 12-week period, corresponding to 57% sensitivity and 
      88% specificity. The MCID was 7 points (95% CI: -10, 28) over a 24-week period, 
      with 85% sensitivity and 62% specificity. CONCLUSION: A change in VISA-A score of 
      at least 14 points after 12 weeks or at least 7 points after 24 weeks of exercise 
      therapy and an injection reflects a meaningful change for physically active 
      patients with midportion AT. J Orthop Sports Phys Ther 2021;51(10):510-516. 
      doi:10.2519/jospt.2021.10040.
FAU - Lagas, Iris F
AU  - Lagas IF
FAU - van der Vlist, Arco C
AU  - van der Vlist AC
FAU - van Oosterom, Robert F
AU  - van Oosterom RF
FAU - van Veldhoven, Peter L J
AU  - van Veldhoven PLJ
FAU - Reijman, Max
AU  - Reijman M
FAU - Verhaar, Jan A N
AU  - Verhaar JAN
FAU - de Vos, Robert-Jan
AU  - de Vos RJ
LA  - eng
PT  - Journal Article
PL  - United States
TA  - J Orthop Sports Phys Ther
JT  - The Journal of orthopaedic and sports physical therapy
JID - 7908150
RN  - 0 (Anesthetics, Local)
RN  - 98PI200987 (Lidocaine)
SB  - IM
MH  - Achilles Tendon/*injuries
MH  - Adult
MH  - Anesthetics, Local
MH  - Cohort Studies
MH  - Exercise Therapy/*methods
MH  - Humans
MH  - Injections, Intralesional/*methods
MH  - Lidocaine/*therapeutic use
MH  - Male
MH  - Middle Aged
MH  - *Minimal Clinically Important Difference
MH  - Prospective Studies
MH  - Surveys and Questionnaires/*standards
MH  - Tendinopathy/*therapy
OTO - NOTNLM
OT  - Achilles tendon
OT  - MCID
OT  - PASS
OT  - patient-reported outcomes
OT  - treatment outcomes
EDAT- 2021/10/02 06:00
MHDA- 2021/10/21 06:00
CRDT- 2021/10/01 05:35
PHST- 2021/10/01 05:35 [entrez]
PHST- 2021/10/02 06:00 [pubmed]
PHST- 2021/10/21 06:00 [medline]
AID - 10.2519/jospt.2021.10040 [doi]
PST - ppublish
SO  - J Orthop Sports Phys Ther. 2021 Oct;51(10):510-516. doi: 
      10.2519/jospt.2021.10040.